
What’s new: China granted emergency approval for a second non-injectable Covid-19 vaccine as the country battles a surge in cases while easing its stringent “zero-Covid” disease-control policy.
A product developed by Beijing Wantai Biological Pharmacy Enterprises Co. Ltd. (603392.SH) together with the University of Hong Kong and Xiamen University won a regulatory green light, the company said Monday. The vaccine is delivered via syringe through a special tip designed to produce a mist.